Advertisement

Evaluation of the use of therapeutic footwear in people with diabetes mellitus – a scoping review

  • Juliana Vallim JorgettoEmail author
  • Mônica Antar Gamba
  • Denise Miyuki Kusahara
Review article
  • 6 Downloads

Abstract

Foot ulcers are one of the major complications of Diabetes Mellitus and are associated with increasing rates of morbidity and mortality. It is estimated that 2% of diabetic patients present lesions in the feet, with relapse rates between 30% and 40% in the first year after healing of the first ulcerations. Therapeutic footwear is one of the main strategies to prevent foot ulceration. OBJECTIVES: To identify in the literature aspects related to the recommendation of health professionals and the use of therapeutic footwear by patients with Diabetes Mellitus. MATERIALS AND METHODS: Scoping review of literature in the Scopus, Scielo, Pubmed and Cochrane databases, using diabetic foot crosswords and therapeutic footwear. RESULTS: Twenty-six articles were included in this review. The majority was systematic reviews (46.15%) with published date from 2016 (38.5%). Of the 26 articles included, 10 (38.5%) referred to adherence to the use of footwear, 10 (38.5%) the difficulty to evaluate the effectiveness of the intervention and 6 (23.0%) to changes in the balance and biomechanics patterns In the studies, the use of therapeutic footwear is linked to the reduction of the risk of ulceration or its recurrence in people with diabetes who already have diabetic neuropathy as chronic complication of the disease. CONCLUSIONS: Therapeutic footwear for diabetics was able to produce significant reductions of peak plantar pressure in static and dynamic analysis, being more efficient than a common footwear, and could contribute to the prevention of injuries associated with diabetic foot.

Keywords

Diabetes mellitus Diabetic neuropathy Therapeutic footwear Diabetic foot 

Abbreviations

COCHRANE

Cochrane Library

DECS

Health Sciences Descriptores

DM

Diabetes Mellitus

IDF

Internacional Diabetes Foot Consensus

IPA

Interpretive Phenomenological Analysis

JBI

Joanna Briggs Institute

MESH

Medical Subject Headings Section

NDP

Peripheral Diabetic Neuropathy

NHMRC

National health Medical Research Council

PICU

Patient, intervention, comparison and outcomes

PUBMED

National Library of Medicine of the USA

UNIFESP

University of São Paulo

Notes

Acknowledgements

To the National Council of Scientific and Technological Development (CNPq) for fomenting the research process 433478 / 2018-7.

Funding

To the National Council of Scientific and Technological Development (CNPq) for fomenting the research process 433478 / 2018–7.

References

  1. 1.
    Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes. 2006;55(3):806–12.CrossRefGoogle Scholar
  2. 2.
    Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle diabetes study. Diabetes Care. 2005;28(10):2441–7.CrossRefGoogle Scholar
  3. 3.
    Abbott CA, et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;7:1071–5.CrossRefGoogle Scholar
  4. 4.
    Ghanassia E, Villon L, Thuan dit Dieudonne JF, Boegner C, Avignon A, Sultan A. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care. 2008;31(7):1288–92.CrossRefGoogle Scholar
  5. 5.
    Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008;24(Suppl 1):S3–6.CrossRefGoogle Scholar
  6. 6.
    Giacomozzi C, D'Ambrogi E, Cesinaro S, Macellari V, Uccioli L. Muscle performance and ankle joint mobility in long-term patients with diabetes. BMC Musculoskelet Disord. 2008;9:99.CrossRefGoogle Scholar
  7. 7.
    Lavery LA, Peters EJ, Armstrong DG. What are the most effective interventions in preventing diabetic foot ulcers? Int Wound J. 2008;5(3):425–33.CrossRefGoogle Scholar
  8. 8.
    Bacarin TA, Sacco IC, Hennig EM. Plantar pressure distribution patterns during gait in diabetic neuropathy patients with a history of foot ulcers. Clinics (Sao Paulo). 2009;64(2):113–20.CrossRefGoogle Scholar
  9. 9.
    Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52(3):398–407.CrossRefGoogle Scholar
  10. 10.
    Rizzo L, Tedeschi A, Fallani E, Coppelli A, Vallini V, Iacopi E, et al. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Low Extrem Wounds. 2012;11:59–64.CrossRefGoogle Scholar
  11. 11.
    Pham H, et al. Screening techniques to identify people at high risk for diabetic foot ulceration - a prospective multicenter trial. Diabetes Care. 2000;23:606–11.CrossRefGoogle Scholar
  12. 12.
    Van Netten JJ, et al. Diabetic foot Australia guideline on footwear for people with diabetes. J Foot Ankle Res. 2018;11:2.CrossRefGoogle Scholar
  13. 13.
    National Health & Medical Research Council (NHMRC) Guideline. National evidence-based guideline on prevention, identification and management of foot complications in diabetes (Part of the guidelines on management of type 2 diabetes). Melbourne: Baker IDI Heart & Diabetes Institute; 2011.Google Scholar
  14. 14.
    International Diabetes Federation (IDF). International Working Group on the Diabetic Foot Prevention and Management of Foot Problems in Diabetes Guidance Documents and Recommendations; 2017.Google Scholar
  15. 15.
    International Diabetes Federation (IDF). International Working Group on the Diabetic Foot Prevention and Management of Foot Problems in Diabetes Guidance Documents and Recommendations; 2015.Google Scholar
  16. 16.
    Cisneros LL. Avaliação de um programa para prevenção de úlceras neuropáticas em portadores de diabetes. Rev Bras Fis. 2010;14(1).Google Scholar
  17. 17.
    Bus SA, Valk GD, van Deursen RW, Armstrong DG, Caravaggi C, Hlaváček P, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev. 2008;24(Suppl 1):S162–80.CrossRefGoogle Scholar
  18. 18.
    Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes a multicenter randomized controlled trial. Diabetes Care. 2013;36:4109–16.CrossRefGoogle Scholar
  19. 19.
    Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm, Florianópolis. Out-Dez. 2008;17(4):758–64.Google Scholar
  20. 20.
    Beyea S, Nicoll LH. Writing an integrative review. AORN J. 1998;67(4):877–80.CrossRefGoogle Scholar
  21. 21.
    Whittemore R, Knal K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.CrossRefGoogle Scholar
  22. 22.
    The Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual: 2011 edition. Available from: http://joannabriggs.org/assets/docs/sumari/ReviewersManual-2011.pdf. Accessed 13 May 2019.
  23. 23.
    Mark LJ, et al. Perceived usability and use of custom-made footwear in diabetic patients at high risk for foot ulceration. J Rehabil Med. 2014;46:357–62.CrossRefGoogle Scholar
  24. 24.
    Paton JS, Roberts A, Bruce GK, Marsden J. Does footwear affect balance? The views and experiences of people with diabetes and neuropathy who have fallen. J Am Podiatr Med Assoc. 2013;103(6):508–15.CrossRefGoogle Scholar
  25. 25.
    Healy A, Naemi R, Chockalingam N. The effectiveness of footwear and other removable off-loading devices in the treatment of diabetic foot ulcers: a systematic review. Curr Diabetes Rev. 2014;10(4):215–30.CrossRefGoogle Scholar
  26. 26.
    Arts ML, et al. Offloading effect of therapeutic footwear in patients with diabetic neuropathy at high risk for plantar foot ulceration. Diabet Med. 2012;29(12):1534–41.CrossRefGoogle Scholar
  27. 27.
    Lázaro-Martínez JL, Aragón-Sánchez J, Álvaro-Afonso FJ, García-Morales E, García-Álvarez Y, Molines-Barroso RJ. The best way to reduce reulcerations: if you understand biomechanics of the diabetic foot, you can do it. Int J Low Extrem Wounds. 2014;13(4):294–319.  https://doi.org/10.1177/1534734614549417 Epub 2014 Sep 25.CrossRefGoogle Scholar
  28. 28.
    Waaijman R, et al. Pressure-reduction and preservation in custom-made footwear of patients with diabetes and a history of plantar ulceration. Diabet med. 2012. Dec. 2012;29(12):1542–9.Google Scholar
  29. 29.
    Pataky Z, et al. Intelligent footwear for diabetic. Rev Med Suisse. 2016;12(502):143–7.Google Scholar
  30. 30.
    Bus SA, Armstrong DG, van Deursen RW, Lewis JEA, Caravaggi CF, Cavanagh PR, et al. IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl. 1):25–36.CrossRefGoogle Scholar
  31. 31.
    Elraiyah T, et al. A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. J Vasc Surg. 2016;63(2 Suppl):59S–68S.e1-2.CrossRefGoogle Scholar
  32. 32.
    Arts ML, Bus SA. Twelve steps per foot are recommended for valid and reliable in-shoe plantar pressure data in neuropathic diabetic patients wearing custom made footwear. Clin Biomech (Bristol, Avon). 2011;26(8):880–4.  https://doi.org/10.1016/j.clinbiomech.2011.05.001.CrossRefGoogle Scholar
  33. 33.
    Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32(Suppl. 1):195–200.CrossRefGoogle Scholar
  34. 34.
    Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American podiatric medical association and the Society for Vascular Medicine. J Vasc Surg. 2016 Feb;63(2 Suppl):3S–21S.CrossRefGoogle Scholar
  35. 35.
    Bus SA. The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence. Plast Reconstr Surg. 2016;138(3 Suppl):179S–87S.CrossRefGoogle Scholar
  36. 36.
    Paton SJ, et al. Effects of foot and ankle devices on balance, gait and falls in adults with sensory perception loss: a systematic review. JBI Database System Rev Implement Rep. 2016;14(12):127–62.CrossRefGoogle Scholar
  37. 37.
    Schaper NC et al. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance documents. Diabetes/Metabolism Research and Reviews32,(S1) Supplement Article, 2015.Google Scholar
  38. 38.
    Dy SM et al. Preventing complications and treating symptoms of diabetic peripheral neuropathy. 2017 Mar. report no.: 17-EHC005-EF. AHRQ Comparative Effectiveness Reviews.Google Scholar
  39. 39.
    Padilha AP et al. Manual de cuidados às pessoas com diabetes e pé diabético: Construção por SCOPING STUDY. Texto Contexto Enferm. 26 (4) Florianópolis. 2018.Google Scholar
  40. 40.
    Even N. Tratamiento de las ulceraciones diabéticas en la consulta del pedicuro-podólogo, acompañamiento y prevención. EMC – Podologia. 2016;18(3):1–10.CrossRefGoogle Scholar
  41. 41.
    Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD002302.Google Scholar
  42. 42.
    Chen WM, Lee SJ, Lee PV. Plantar pressure relief under the metatarsal heads: therapeutic insole design using three-dimensional finite element model of the foot. J Biomech. 2015;48(4):659–65.CrossRefGoogle Scholar
  43. 43.
    van Netten JJ, et al. Diabetic Foot Australia guideline on footwear for people with diabetes. Journal of Foot and Ankle Research. 2018;11:2.CrossRefGoogle Scholar
  44. 44.
    Sicco A. et al. Evaluation and optimization of therapeutic footwear for neuropatic diabetic foot patients using in-shoe plantar pressure analysis. Diabetes Care (2001);34(7):1595–1600.Google Scholar
  45. 45.
    Paton JS, Roberts A, Bruce GK, Marsden J. Patients' experience of therapeutic footwear whilst living at risk of neuropathic diabetic foot ulceration: an interpretative phenomenological analysis (IPA). J Foot Ankle Res. 2014;7(1):16.CrossRefGoogle Scholar
  46. 46.
    Lavery LA, LaFontaine J, Higgins KR, Lanctot DR, Constantinides G. Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients. Adv Skin Wound Care. 2012;25(11):519–24 quiz 525-6.CrossRefGoogle Scholar
  47. 47.
    Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 2005;25(1):CD001488.Google Scholar
  48. 48.
    Lott DJ, et al. Effect of footwear and orthotic devices on stress reduction and soft tissue strain of the neuropathic foot. Clin Biomech (Bristol, Avon). 2007;22(3):352–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Public Health in the Collective Dimension, Paulista School of NursingFederal University of São Paulo – UNIFESPSão João da Boa Vista-SPBrazil
  2. 2.Department of Administration Applied to Nursing and Collective Health, School of NursingFederal University of São Paulo – UNIFESPSão PauloBrazil
  3. 3.Department of Pediatric Nursing of the Paulista School of NursingFederal University of São Paulo – UNIFESPSão PauloBrazil

Personalised recommendations